Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL-BP 2
NCT06677970Phase 3Recruiting
- Sponsor
- Yonsei University
- Start
- Oct 2024
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phenylephrine in ischemic stroke, sponsored by Yonsei University. Started Oct 2024; status: recruiting.
02
Drugs
phenylephrine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06677970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677970.